Key result
Treatment with corticosteroids, hydroxychloroquine, mycophenolate mofetil, and anti-heart failure medications led to dramatic symptom responses in the first few weeks.
Why the study?
Myocarditis is an uncommon manifestation of systemic lupus erythematosus that can range from subclinical to life-threatening, making early recognition and treatment critical.
Does treatment with steroids, hydroxychloroquine, and mycophenolate mofetil improve symptoms in patients with lupus myocarditis?
Case Report (n=2)
Does treatment with steroids, hydroxychloroquine, and mycophenolate mofetil improve symptoms in patients with lupus myocarditis?
Early recognition and treatment of lupus myocarditis with immunosuppressants and heart failure medications can lead to dramatic symptom improvement.
No takes yet. Share an insight, caveat, or question.
Consider SLE in unexplained myocarditis; hypothesis-generating for prevalence and optimal management.
Al-Nokhatha et al. (2019) conducted a case report in Systemic lupus erythematosus with myocarditis (n=2). Corticosteroids, hydroxychloroquine, mycophenolate mofetil, and anti-heart failure medications was evaluated on Symptom response. Treatment with corticosteroids, hydroxychloroquine, mycophenolate mofetil, and anti-heart failure medications led to dramatic symptom responses in the first few weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: